Balaxi Pharmaceuticals Ltd. (BALAXI)
Market Closed
16 Oct, 10:00 AM
XNSE XNSE Primary ₹
22. 09
-0.04
-0.1808%
₹
4.17B Market Cap
- P/E Ratio
2% Div Yield
13,444 Volume
- Eps
₹ 22.13
Previous Close Want to track BALAXI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Balaxi Pharmaceuticals Ltd. (BALAXI) Statistics
Valuation metrics
Market Cap 4.17B
Enterprise value 1.66B
Trailing P/E (ttm) 49.62
Forward P/E -
PEG ratio -0.57
Price/Sales (ttm) 0.44
Price/Book (mrq) 0.49
Enterprise Value/Revenue 0.59
Enterprise Value/EBITDA 15.23
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 22.03K
Average volume (90 days) 32.28K
Price summary
52-Week low 15.2
52-Week high 43.85
Beta -
50-Day moving average 23.04
200-Day moving average 24
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 5:1
Last split Date 30 May 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.01%
Operating margin 0.02%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 51.09
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.44
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.64
Total debt (mrq) -
Total Debt/Equity (mrq) 0.23
Current ratio (mrq) 4.51%
Book value per share (mrq) 45.12
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
